All News #Library
Rare Diseases
Palatin Expects $11.5M Financing to Cure NYSE American Delisting
07 May 2025 //
PR NEWSWIRE
Palatin’s MC4R Agonist PL7737 Gets FDA Orphan Status For Obesity
25 Mar 2025 //
PR NEWSWIRE

Market Place
Sourcing Support